机构:[1]Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, 430022 Wuhan, China华中科技大学同济医学院附属协和医院[2]Department of Hematology, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China[3]Intensive Care Units of Wuhan Third Hospital, Tongren Hospital of Wuhan University, Wuhan, China[4]Key Laboratory for Molecular Diagnosis of Hubei Province, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China[5]Wuhan Jin-Yin-Tan Hospital, Wuhan, China[6]Department of Hematology, General Hospital of Central Theater Command, PLA, 300700 Wuhan, China[7]Medical Records Statistics Department of Wuhan Third Hospital, Tongren Hospital of Wuhan University, Wuhan, China[8]Center for Hematology Research, Department of Immunology and Inflammation, Imperial College London, London, UK
We studied admission and dynamic demographic, hematological and biochemical co-variates in 1449 hospitalized subjects with coronavirus infectious disease-2019 (COVID-19) in five hospitals in Wuhan, Hubei province, China. We identified two admission co-variates: age (Odds Ratio [OR] = 1.18, 95% Confidence Interval [CI] [1.02, 1.36];P = 0.026) and baseline D-dimer (OR = 3.18 [1.48, 6.82];P = 0.003) correlated with an increased risk of death in persons with COVID-19. We also found dynamic changes in four co-variates, Delta fibrinogen (OR = 6.45 [1.31, 31.69];P = 0.022), Delta platelets (OR = 0.95 [0.90-0.99];P = 0.029), Delta C-reactive protein (CRP) (OR = 1.09 [1.01, 1.18];P = 0.037), and Delta lactate dehydrogenase (LDH) (OR = 1.03 [1.01, 1.06];P = 0.007) correlated with an increased risk of death. The potential risk factors of old age, high baseline D-dimer, and dynamic co-variates of fibrinogen, platelets, CRP, and LDH could help clinicians to identify and treat subjects with poor prognosis.
基金:
Funded by the Natural Science
Foundation of China (NSFC; 81974009 to QL, 81974221 and
81470330 to ZC) and the Fundamental Research Funds for the Central
Universities (2020kfyXGYJ086 to QL).